Name | (S)-2-(4-((((S)-2-Amino-5-methyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid |
---|---|
Synonyms |
N-(5-methyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-Amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl]methyl}amino)benzoyl]-L-glutamic acid L-glutamic acid, N-[4-[[[(6S)-1,2,5,6,7,8-hexahydro-4-hydroxy-2-imino-5-methyl-6-pteridinyl]methyl]amino]benzoyl]- L-5-methyltetrahydrofolic acid (6S)-5-Methyltetrahydrofolic acid 5-Methyl-(6S)-tetrahydrofolic acid 5-Methyltetrahydrofolate L-5-Methyltetrahydrofolate Levomefolic acid Levomefolic Acid (See also L375720) N-[4-({[(6S)-2-Amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid L-Glutamic acid, N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]- 5-methyltetrahydrofolic acid levomefolinic acid (2S)-2-{[4-({[(6S)-2-Amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydro-6-pteridinyl]methyl}amino)benzoyl]amino}pentanedioic acid |
Description | Levomefolic acid (5-MTHF) is the natural, active form of folic acid used at the cellular level for DNA reproduction, the cysteine cycle and the regulation of homocysteine among other functions. IC50 value: Target: Folate analogLevomefolic acid has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers. Levomefolic acid (5-MTHF) has the prominent antioxidant activity. A high dose of 5-MTHF or folic acid does not influence Natural killer (NK) cell function in vitro. |
---|---|
Related Catalog | |
References |
[6]. Levomefolic acid |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C20H25N7O6 |
Molecular Weight | 459.456 |
Exact Mass | 459.186646 |
PSA | 202.77000 |
LogP | -2.61 |
Index of Refraction | 1.733 |
~% 31690-09-2 |
Literature: WO2013/25203 A1, ; |
Precursor 1 | |
---|---|
DownStream 0 |